Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Chen, Shuang ^a   Jiang, Hongmei ^a   Wu, Xiaosong ^a   Fang, Jun ^a,b,c  

^a HUNAN AGRICULTURAL UNIVERSITY   (China)

^b HUNAN UNIVERSITY   (China)

^c National Res Center of Engineering Tech for Utilization of Functional Ingredients from Botanicals   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOBESITY AGENT; QUERCETIN; ANTIOXIDANT;

ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CAPILLARY PERMEABILITY; DIETARY SUPPLEMENT; HUMAN; INFLAMMATION; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVIEW; SECRETION (PROCESS); THERAPY EFFECT; THROMBOCYTE AGGREGATION; ANIMAL; BLOOD; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DIET; INSULIN RESISTANCE; OBESITY, ABDOMINAL; PERMEABILITY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; DIET; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPID PEROXIDATION; OBESITY; OBESITY, ABDOMINAL; PERMEABILITY; PLATELET AGGREGATION; QUERCETIN;

EID: 85006056887     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/9340637     Document Type: Review

References (46)

1. K. G. M. M. Alberti, R. H. Eckel, S. M. Grundy et al., "Harmonizing the metabolic syndrome: a joint interimstatement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity, " Circulation, vol. 120, no. 16, pp. 1640-1645, 2009.
2. M. Y. Donath and S. E. Shoelson, "Type 2 diabetes as an inflammatory disease, " Nature Reviews Immunology, vol. 11, no. 2, pp. 98-107, 2011.
3. N. Ouchi, J. L. Parker, J. J. Lugus, K. Walsh, "Adipokines in inflammation andmetabolic disease, "Nature Reviews Immunology, vol. 11, no. 2, pp. 85-97, 2011.
4. D. Zozulinska and B. Wierusz-Wysocka, "Type 2 diabetes mellitus as inflammatory disease, " Diabetes Research and Clinical Practice, vol. 74, no. 2, pp. S12-S16, 2006.
5. T. Kawai, T. Masaki, S. Doi et al., "PPAR-agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-, " Laboratory Investigation, vol. 89, no. 1, pp. 47-58, 2008.
6. J. M. Davis, E. A. Murphy, M. D. Carmichael, "Effects of the dietary flavonoid quercetin upon performance and health, " Current SportsMedicine Reports, vol. 8, no. 4, pp. 206-213, 2009.
7. M. P. Portillo, "Beneficial effects of quercetin on obesity and diabetes, " The Open Nutraceuticals Journal, vol. 4, no. 1, pp. 189-198, 2011.
8. G. S. Hotamisligil, "Inflammation and metabolic disorders, " Nature, vol. 444, no. 7121, pp. 860-867, 2006.
9. H. S. Park, J. Y. Park, R. Yu, "Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-and IL-6, " Diabetes Research and Clinical Practice, vol. 69, no. 1, pp. 29-35, 2005.
10. H. H. M. Hermsdorff, M. A. Zulet, B. Puchau, J. A. Martnez, "Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status fromhealthy young adults, " Inflammation, vol. 34, no. 3, pp. 161-170, 2011.
11. S. Tateya, F. Kim, Y. Tamori, "Recent advances in obesityinduced inflammation and insulin resistance, " Frontiers in Endocrinology, vol. 4, article 93, 2013.
12. E. Lapice, S. Maione, L. Patti et al., "Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy nonobese people, " Diabetes Care, vol. 32, no. 9, pp. 1734-1736, 2009.
13. Y. Chen, R. Duan, H. Xue, Y. Liu, G. Cheng, "Dietary calcium, diary intakes and childhood overweight/obesity in Chinese children and adolescents: a cross-sectional study, " Obesity Research & Clinical Practice, vol. 8, supplement 1, p. 17, 2014.
14. R. J. Gel, S. M. Jensen, H. Fri, C. Mgaard, K. F. Michaelsen, "Obesity, inflammation and metabolic syndrome in Danish adolescents, " Acta Paediatrica, International Journal of Paediatrics, vol. 101, no. 2, pp. 192-200, 2012.
15. P. Giordano, G. C. Del Vecchio, V. Cecinati et al., "Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents, " European Journal of Pediatrics, vol. 170, no. 7, pp. 845-850, 2011.
16. J. Warnberg, E. Nova, L. A. Moreno et al., "Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study, " The American Journal of Clinical Nutrition, vol. 84, no. 3, pp. 505-512, 2006.
17. J. P. Brown, "A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds, " Mutation Research/Reviews in Genetic Toxicology, vol. 75, no. 3, pp. 243-277, 1980.
18. A. E. Mitchell, Y.-J. Hong, E. Koh et al., "Ten-year comparison of the influence of organic and conventional crop management practices on the content of flavonoids in tomatoes, " Journal of Agricultural and Food Chemistry, vol. 55, no. 15, pp. 6154-6159, 2007.
19. L. Sampson, E. Rimm, P. C. H. Hollman, J. H. M. de Vries, M. B. Katan, "Flavonol and flavone intakes in US health professionals, " Journal of the American Dietetic Association, vol. 102, no. 10, pp. 1414-1420, 2002.
20. C. Sun, H. Wang, D. Wang, Y. Chen, Y. Zhao, W. Xia, "Using an FFQ to assess intakes of dietary flavonols and flavones among female adolescents in the Suihua area of northern China, " Public Health Nutrition, vol. 18, no. 4, pp. 632-639, 2014.
21. Y. Zhang, Y. Li, C. Cao et al., "Dietary flavonol and flavone intakes and their major food sources in Chinese adults, " Nutrition and Cancer, vol. 62, no. 8, pp. 1120-1127, 2010.
22. N. Leyva-Lopez, V. Nair, W. Y. Bang, L. Cisneros-Zevallos, J. B. Heredia, "Protective role of terpenes and polyphenols from three species of Oregano (Lippia graveolens, Lippia palmeri and Hedeoma patens) on the suppression of lipopolysaccharideinduced inflammation inRAW264. 7 macrophage cells, " Journal of Ethnopharmacology, vol. 187, pp. 302-312, 2016.
23. K. M. Lee, M. K. Hwang, D. E. Lee, K. W. Lee, H. J. Lee, "Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells, " Journal of Agricultural and Food Chemistry, vol. 58, no. 9, pp. 5815-5820, 2010.
24. J. S. Yoon, M. K. Chae, S. Y. Lee, E. J. Lee, "Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy, " British Journal of Ophthalmology, vol. 96, no. 8, pp. 1117-1121, 2012.
25. P. Ramyaa, R. Krishnaswamy, V. V. Padma, "Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2 cells-up regulation of Nrf2 expression and down regulation of NF-B andCOX-2, " Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 1840, no. 1, pp. 681-692, 2014.
26. N. Mrvova, M. Skandk, M. Kuniakova, L. Rackova, "Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester, " Neurochemistry International, vol. 90, pp. 246-254, 2015.
27. M. Mueller, S. Hobiger, A. Jungbauer, "Anti-inflammatory activity of extracts from fruits, herbs and spices, " Food Chemistry, vol. 122, no. 4, pp. 987-996, 2010.
28. M. Comalada, I. Ballester, E. Bailon et al., "Inhibition of proinflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship, " Biochemical Pharmacology, vol. 72, no. 8, pp. 1010-1021, 2006.
29. D. Ribeiro, M. Freitas, S. M. Tome et al., "Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine/chemokine production in human whole blood, " Inflammation, vol. 38, no. 2, pp. 858-870, 2015.
30. S. Egert, A. Bosy-Westphal, J. Seiberl et al., "Quercetin reduces systolic blood pressure and plasma oxidised lowdensity lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study, " British Journal of Nutrition, vol. 102, no. 7, pp. 1065-1074, 2009.
31. J. Zheng, J. Wu, J. Chen et al., "Therapeutic effects of quercetin on early inflammation in hypertriglyceridemia-related acute pancreatitis and its mechanism, " Pancreatology, vol. 16, no. 2, pp. 200-210, 2016.
32. J. Hosek and K. Smejkal, "Flavonoids as anti-inflammatory agents, " in Encyclopedia of Inflammatory Diseases, pp. 1-17, Springer, Basel, Switzerland, 2015.
33. C. Angeloni and S. Hrelia, "Quercetin reduces inflammatory responses in LPS-stimulated cardiomyoblasts, " Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 837104, 8 pages, 2012.
34. S. Fujioka, J. Niu, C. Schmidt et al., "NF-B and AP-1 connection: mechanism of NF-B-dependent regulation of AP-1 activity, "Molecular andCellular Biology, vol. 24, no. 17, pp. 7806-7819, 2004.
35. A. Richmond and J. Yang, "The role of NF-B in modulating antitumor immunity, " OncoImmunology, vol. 5, no. 1, Article ID e1005522, 2016.
36. Y. Qiao, H. He, P. Jonsson, I. Sinha, C. Zhao, K. Dahlman-Wright, "AP-1 is a key regulator of proinflammatory cytokine TNF-mediated triple-negative breast cancer progression, " Journal of Biological Chemistry, vol. 291, no. 10, pp. 5068-5079, 2016.
37. S. R. Panicker, P. Sreenivas, M. S. Babu, D. Karunagaran, C. C. Kartha, "Quercetin attenuates monocyte chemoattractant protein-1 gene expression in glucose primed aortic endothelial cells through NF-B and AP-1, " Pharmacological Research, vol. 62, no. 4, pp. 328-336, 2010.
38. S. Chirumbolo, "The role of quercetin, flavonols and flavones in modulating inflammatory cell function, " Inflammation & Allergy-Drug Targets, vol. 9, no. 4, pp. 263-285, 2010.
39. J. Ahn, H. Lee, S. Kim, J. Park, T. Ha, "Corrigendum to 'The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways'[Biochemical and Biophysical Research Communications 373 (2008) 545-549]
40. " Biochemical and Biophysical Research Communications, vol. 404, no. 1, p. 579, 2008.
41. C. H. Jung, I. Cho, J. Ahn, T.-I. Jeon, T.-Y. Ha, "Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes, " Phytotherapy Research, vol. 27, no. 1, pp. 139-143, 2013.
42. P. Haddad, H. Eid, A. Nachar, F. Thong, G. Sweeney, "The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes, " Pharmacognosy Magazine, vol. 11, no. 41, p. 74, 2015.
43. S.-M. Jeong, M.-J. Kang, H.-N. Choi, J.-H. Kim, J.-I. Kim, "Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice, " Nutrition Research and Practice, vol. 6, no. 3, pp. 201-207, 2012.
44. P.-B. Lai, L. Zhang, L.-Y. Yang, "Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-1 and connective tissue growth factor in streptozotocin-induced diabetic rats, " Renal Failure, vol. 34, no. 1, pp. 83-87, 2012.
45. P. S. Chaudhry, J. Cabrera, H. R. Juliani, S. D. Varma, "Inhibition of human lens aldose reductase by flavonoids, sulindac and indomethacin, " Biochemical Pharmacology, vol. 32, no. 13, pp. 1995-1998, 1983.
46. P. Valensi, C. Le Devehat, J.-L. Richard et al., "A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy: a preliminary report, " Journal of Diabetes and Its Complications, vol. 19, no. 5, pp. 247-253, 2005.